Rankings
▼
Calendar
BDX Q4 2024 Earnings — Becton, Dickinson and Company Revenue & Financial Results | Market Cap Arena
BDX
Becton, Dickinson and Company
$60B
Q4 2024 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$5.4B
+6.9% YoY
Gross Profit
$2.5B
45.7% margin
Operating Income
$622M
11.4% margin
Net Income
$400M
7.4% margin
EPS (Diluted)
$1.45
QoQ Revenue Growth
+9.0%
Cash Flow
Operating Cash Flow
$1.2B
Free Cash Flow
$882M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$57.3B
Total Liabilities
$31.4B
Stockholders' Equity
$25.9B
Cash & Equivalents
$1.9B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5.4B
$5.1B
+6.9%
Gross Profit
$2.5B
$1.7B
+46.2%
Operating Income
$622M
$349M
+78.2%
Net Income
$400M
$108M
+270.4%
Revenue Segments
Medical
$2.8B
52%
Life Sciences
$1.3B
25%
Interventional
$1.3B
23%
Geographic Segments
UNITED STATES
$3.1B
57%
Non-US
$2.3B
43%
← FY 2024
All Quarters
Q1 2025 →